Replication of Hepatitis C Virus in Cultured Non‐neoplastic Human Hepatocytes

We established a replication system for hepatitis C virus (HCV) using the PH5CH non‐neoplastic human hepatocyte line that had been immortalized with simian virus 40 large T antigen. In cells inoculated with sera derived from two HCV‐positive blood donors, positive‐stranded HCV RNA was detected up to 30 days postinoculation (p.i.). Semi‐quantitative analysis of HCV RNA revealed that HCV multiplied during the period of culture. Sequence analysis of the HCV hypervariable region 1 (HVR1) in both cases indicated that HVR1 populations from the cells at 8 days p.i. were apparently different from those of the original inocula. HVR1 populations in infected cells became homogeneous or just a few species were selected over time. These results suggest that HCV is replicating in the human hepatocyte PH5CH cells. This culture system will be useful for detailed studies of the biological effects of HCV in human hepatocytes.

[1]  A. Kirn,et al.  In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. , 1995, The Journal of general virology.

[2]  N. Kato,et al.  Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. , 1995, Biochemical and biophysical research communications.

[3]  E. Schreier,et al.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. , 1995, Virology.

[4]  R. Purcell,et al.  Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.

[5]  N. Kato,et al.  Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. , 1995, Biochemical and biophysical research communications.

[6]  T. Fuerst,et al.  Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. , 1994, Virology.

[7]  N. Kato,et al.  Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection , 1994, Journal of virology.

[8]  N. Kato,et al.  Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier , 1994, International journal of cancer.

[9]  N. Kato,et al.  Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Purcell,et al.  Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Kato,et al.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.

[12]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[13]  N. Kato,et al.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Sugimura,et al.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Kato,et al.  A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. , 1990, Biochemical and biophysical research communications.

[16]  M. Onji,et al.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Kato,et al.  Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. , 1990, Japanese journal of cancer research : Gann.

[18]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[19]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[20]  M. Nei,et al.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.